Literature DB >> 7664666

Processing of prothyrotropin-releasing hormone (Pro-TRH) by bovine intermediate lobe secretory vesicle membrane PC1 and PC2 enzymes.

T C Friedman1, Y P Loh, N X Cawley, N P Birch, S S Huang, I M Jackson, E A Nillni.   

Abstract

TRH is synthesized from a larger 26-kilodalton (kDa) prohormone (pro-TRH). Rat pro-TRH contains five copies of the TRH progenitor sequence (Gln-His-Pro-Gly) and seven other cryptic peptides. Each of the five TRH progenitor sequences is flanked by pairs of basic amino acids. We used a bovine intermediate lobe secretory vesicle membrane preparation, which contains the prohormone convertases (PCs) PC1 and PC2, to study the in vitro processing of pro-TRH. Pro-TRH was radiolabeled using [3H]Leu in AtT20 cells transfected with prepro-TRH complementary DNA, and the labeled 26-kDa pro-TRH was isolated from the cell extract by preparative sodium dodecyl sulfate-gel electrophoresis. Incubation of [3H]pro-TRH with the intermediate lobe secretory vesicle membrane preparation was followed by immunoprecipitation with antibodies specific for various regions of the pro-TRH sequence, and the immunoprecipitates were analyzed by sodium dodecyl sulfate-gel electrophoresis. Immunoprecipitation of the reaction mixture with anti-pCC10 antibody (an antibody that recognizes the intact precursor and amino-terminal intermediate products of processing) showed a time-dependent appearance of a 15-kDa and a 6-kDa peptide and, at times, a 3.8-kDa peptide with diminution of the 26-kDa substrate. Immunoprecipitation of the incubate with the C-terminal-directed antibody, pYE17 (an antibody that recognizes the intact precursor and C-terminal intermediate products of processing), showed the generation of 16.5-, 10-, and 5.4-kDa products in a time-dependent manner, with disappearance of the substrate. Western blot analysis demonstrated that the secretory vesicle membrane preparation contains PC1 and PC2. Immunodepletion studies with antiserum specific for PC1 or PC2 demonstrated that PC1 and PC2 can process pro-TRH to these intermediate products. An initial site of cleavage appeared to be either at the 152-153 or the 158-159 pair of basic residues to yield a 15-kDa N-terminal fragment that was then processed to the 6-kDa [TRH-(25-74)] and 3.8-kDa [TRH-(83-112)] forms. The 10-kDa C-terminal peptide generated by this cleavage was then processed to a 5.4-kDa peptide [TRH-(208-255)]. Alternatively, an initial cleavage at the 107-108 or the 112-113 bonds was also observed, yielding a 16.5-kDa C-terminal product that was further processed to the 5.4-kDa peptide. The pH profile for the appearance of both C- and N-terminal products showed a bimodal distribution, with optima at both 5.5 and 7.5. The cleavage of pro-TRH was enhanced by Ca2+ and partially inhibited by Zn2+.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7664666     DOI: 10.1210/endo.136.10.7664666

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Role of a pro-sequence in the secretory pathway of prothyrotropin-releasing hormone.

Authors:  Amparo Romero; Isin Cakir; Charles A Vaslet; Ronald C Stuart; Omar Lansari; Hector A Lucero; Eduardo A Nillni
Journal:  J Biol Chem       Date:  2008-09-08       Impact factor: 5.157

2.  Processing of proaugurin is required to suppress proliferation of tumor cell lines.

Authors:  Akihiko Ozawa; Adam N Lick; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2011-03-24

3.  Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.

Authors:  Akihiko Ozawa; Juan R Peinado; Iris Lindberg
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

Review 4.  Neuroregulation of ProTRH biosynthesis and processing.

Authors:  E A Nillni
Journal:  Endocrine       Date:  1999-06       Impact factor: 3.633

Review 5.  Multifactorial modulation of TRH metabolism.

Authors:  P Joseph-Bravo; R M Uribe; M A Vargas; L Pérez-Martínez; T Zoeller; J L Charli
Journal:  Cell Mol Neurobiol       Date:  1998-04       Impact factor: 5.046

6.  Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH.

Authors:  Nicole E Cyr; Anika M Toorie; Jennifer S Steger; Matthew M Sochat; Samantha Hyner; Mario Perello; Ronald Stuart; Eduardo A Nillni
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

Review 7.  Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs.

Authors:  Eduardo A Nillni
Journal:  Front Neuroendocrinol       Date:  2010-01-13       Impact factor: 8.606

8.  Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.

Authors:  Ippolita Cantuti-Castelvetri; Ledia F Hernandez; Christine E Keller-McGandy; Lauren R Kett; Alex Landy; Zane R Hollingsworth; Esen Saka; Jill R Crittenden; Eduardo A Nillni; Anne B Young; David G Standaert; Ann M Graybiel
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

9.  Glucocorticoids modulate the biosynthesis and processing of prothyrotropin releasing-hormone (proTRH).

Authors:  T O Bruhn; S S Huang; C Vaslet; E A Nillni
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

10.  Stepwise posttranslational processing of progrowth hormone-releasing hormone (proGHRH) polypeptide by furin and PC1.

Authors:  Samuel F Posner; Charles A Vaslet; Michelle Jurofcik; Alisson Lee; Nabil G Seidah; Eduardo A Nillni
Journal:  Endocrine       Date:  2004 Mar-Apr       Impact factor: 3.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.